Truffini & Reggè Farmaceutici S.r.l.

Via Oslavia 18
20134 Mailand
Italy

Phone

truffini.it

About Truffini & Reggè Farmaceutici

Truffini & Reggè, founded in 1917, is an historical, time-proven firm. Its purpose is to formulate, develop and act as a contractor manufacturer for production of solids, chiefly tablets, for several branches of pharmaceutical, cosmetic, herboristic, dietetic and food supplement fields.

Product portfolio of Truffini & Reggè Farmaceutici

Here you will find Truffini & Reggè Farmaceutici S.r.l.

Last viewed contents

Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK Gatersleben) - Gatersleben, Germany

Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK Gatersleben) - Gatersleben, Germany

From beer to useful fats and medicines - The spent grain from beer brewing can be used to make microcapsules that can preserve omega-3 oils and medicines

From beer to useful fats and medicines - The spent grain from beer brewing can be used to make microcapsules that can preserve omega-3 oils and medicines

Simtra BioPharma Solutions - Parsippany, USA

Simtra BioPharma Solutions - Parsippany, USA

Ancient viral DNA shapes modern human placentas - “It’s a reminder that there is much more to learn about our genome and how ancient infections can influence who we are today”

Ancient viral DNA shapes modern human placentas - “It’s a reminder that there is much more to learn about our genome and how ancient infections can influence who we are today”

Chemistry meets biology: controlling artificial cell membranes through catalysis - Researchers develop an artificial metalloenzyme-based platform that enables programmable control of artificial membrane behavior

Chemistry meets biology: controlling artificial cell membranes through catalysis - Researchers develop an artificial metalloenzyme-based platform that enables programmable control of artificial membrane behavior

Merck Invests €70 million to Expand ADC Manufacturing for Novel Cancer Therapies - Triples manufacturing capacity to meet increased global demand for antibody-drug conjugates (ADCs)

Merck Invests €70 million to Expand ADC Manufacturing for Novel Cancer Therapies - Triples manufacturing capacity to meet increased global demand for antibody-drug conjugates (ADCs)

StratifAI Raises €12.5M for Clinical Validation of AI Biomarker Platform for Precision Oncology - Oversubscribed round expand global reach, and unlock multi‑billion‑euro cancer diagnostics market

StratifAI Raises €12.5M for Clinical Validation of AI Biomarker Platform for Precision Oncology - Oversubscribed round expand global reach, and unlock multi‑billion‑euro cancer diagnostics market

New deep-learning tool can tell if your salmon is wild or farmed

New deep-learning tool can tell if your salmon is wild or farmed

Recipharm secures major additional grant to develop AI-enabled manufacturing technologies - Development of an AI-enabled simulator and process control platform, to speed up process development, cut costs and improve manufacturing efficiency

Recipharm secures major additional grant to develop AI-enabled manufacturing technologies - Development of an AI-enabled simulator and process control platform, to speed up process development, cut costs and improve manufacturing efficiency

How a gene shapes the architecture of the human brain

How a gene shapes the architecture of the human brain

Medical_guideline